Invest now
Transgene Biotek Cash Flow Annual
BSE: 526139 | NSE: - | ISIN: INE773D01018 | Sector: Biotechnology & Drugs2.20 -0.23 (-9.47%)Updated : 06 Oct 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | 0.70 | 1.02 | - | 0.00 |
| Net Changein Cash | -0.22 | 0.28 | 0.00 | -0.01 |
| Net Income/ Starting Line | -1.65 | -0.68 | -0.66 | -6.01 |
| Changesin Working Capital | 0.53 | 1.72 | 0.61 | 1.05 |
| Cashfrom Operating Activities | -0.01 | 1.20 | 0.00 | 0.00 |
| Cash Interest Paid | 1.06 | 0.24 | - | - |
| Cashfrom Financing Activities | -0.36 | 0.78 | 0.00 | 0.00 |
| Depreciation/ Depletion | 0.20 | 0.09 | 0.09 | 4.95 |
| Other Investing Cash Flow Items Total | 0.15 | -1.70 | 0.00 | 0.00 |
| period Type | - | - | - | - |
| Non- Cash Items | 0.91 | 0.06 | -0.05 | 0.01 |
| Financing Cash Flow Items | -1.06 | -0.24 | 0.00 | - |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | 0.15 | -1.70 | 0.00 | -0.01 |
| Cash Taxes Paid | - | 0.00 | - | - |
| Capital Expenditures | - | 0.00 | 0.00 | -0.01 |
*All figures in crores except per share values
Transgene Biotek Quick Links
Transgene Biotek Dividend Transgene Biotek Bonus Transgene Biotek News Transgene Biotek AGM Transgene Biotek Rights Transgene Biotek Splits Transgene Biotek Board Meetings Transgene Biotek Key Metrics Transgene Biotek Shareholdings Transgene Biotek Profit Loss Transgene Biotek Balance Sheet Transgene Biotek Q1 Results Transgene Biotek Q2 Results Transgene Biotek Q3 Results Transgene Biotek Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,035.00+40.00(4.02%)
2,079.30+29.30(1.43%)
1,246.00+17.00(1.38%)
11,400.00-549.00 (-4.59%)
2,851.05-96.35 (-3.27%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.